Literature DB >> 14136320

THE EPIDEMIOLOGICAL BASIS FOR THE CONTROL OF INFLUENZA.

A D LANGMUIR, D A HENDERSON, R E SERFLING.   

Abstract

Keywords:  COMMUNICABLE DISEASE CONTROL; EPIDEMIOLOGY; INFLUENZA; INFLUENZA VACCINE; INFLUENZA, ASIAN; MORTALITY; PNEUMONIA; UNITED STATES

Mesh：

Substances：

Year:  1964        PMID： 14136320      PMCID： PMC1254817          DOI： 10.2105/ajph.54.4.563

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  5 in total

1.  ANTIGENIC RELATIONSHIP OF 1961-1963 A2 INFLUENZA VIRUSES TO PROTOTYPE A2 1957 STRAIN.

Authors:  J A MORRIS; M HATANO; R Q ROBINSON; C G AULISIO; J E SMADEL
Journal:  Proc Soc Exp Biol Med       Date:  1963-11

2.  ANTIGENIC VARIATION OF RECENTLY ISOLATED A2 INFLUENZA VIRUSES.

Authors:  H L WEINBERGER; E L BUESCHER; J MCCOWN; J R GAULD
Journal:  Proc Soc Exp Biol Med       Date:  1963-11

3.  Inactivated influenza virus vaccines. Past, present, and future.

Authors:  F M DAVENPORT
Journal:  Am Rev Respir Dis       Date:  1961-02

4.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

5.  Influenza epidemics during 1951-56 with a review of trends.

Authors:  S D COLLINS; J L LEHMANN
Journal:  Public Health Rep       Date:  1957-09       Impact factor: 2.792
  5 in total
  17 in total

1.  Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures.

Authors:  Joshua G Petrie; Suzanne E Ohmit; Emileigh Johnson; Rachel T Cross; Arnold S Monto
Journal:  J Infect Dis       Date:  2011-03-04       Impact factor: 5.226

2.  Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.

Authors:  Marc Lipsitch; Ayan Jha; Lone Simonsen
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

3.  Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.

Authors:  A Delem; W Van Rensburg; I Flaskett
Journal:  J Hyg (Lond)       Date:  1979-10

4.  Immunizable disease occurrence and prevention in Seattle.

Authors:  R T Ravenholt; M J Levinski; M Johnson; A M Ravenholt
Journal:  Public Health Rep       Date:  1965-11       Impact factor: 2.792

5.  The prevention of influenza by influenza vaccine.

Authors:  C H Stuart-Harris
Journal:  Proc R Soc Med       Date:  1967-07-07

6.  A perspective on the significance of pandemic influenza.

Authors:  J Kavet
Journal:  Am J Public Health       Date:  1977-11       Impact factor: 9.308

Review 7.  Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine.

Authors:  Robert M Jacobson; Gregory A Poland
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Influence function methods to assess the effectiveness of influenza vaccine with survey data.

Authors:  Mingmei Tian; Jihnhee Yu; Denise F Lillvis; Albert Vexler
Journal:  Health Serv Res       Date:  2021-10-22       Impact factor: 3.402

9.  Projection of seasonal influenza severity from sequence and serological data.

Authors:  Yuri I Wolf; Anastasia Nikolskaya; Joshua L Cherry; Cecile Viboud; Eugene Koonin; David J Lipman
Journal:  PLoS Curr       Date:  2010-12-03

10.  Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales.

Authors:  Donald R Olson; Kevin J Konty; Marc Paladini; Cecile Viboud; Lone Simonsen
Journal:  PLoS Comput Biol       Date:  2013-10-17       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.